Active substances
Ascorbic acid + Sodium ascorbate
- SFDA 4
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| REDOXON CHEWABLE TAB 500MG | 167,375 mg | Chewable tablet · Oral use | 30 Blister | SAR 12.35 | Generic · OTC | ROCHE | Withdrawn by MAH · Not Marketed |
| VC CHEWABLE TAB | 388,170 mg,mg | Chewable tablet · Oral use | 1 Blister | SAR 9.20 | Generic · OTC | Gulf Pharmaceutical Industries (Julphar) | Withdrawn by MAH · Not Marketed |
| VITA-C 500MG CHEWABLE TAB. | 167, 375 mg | Tablet · Oral use | 40 Blister | SAR 12.60 | Generic · OTC | Tabuk Pharmaceutical Manufacturing Company | Withdrawn by MAH · Not Marketed |
| VITA-C 500MG CHEWABLE TAB. | 167, 375 mg | Tablet · Oral use | 20 Blister | SAR 7.15 | Generic · OTC | Tabuk Pharmaceutical Manufacturing Company | Withdrawn by MAH · Not Marketed |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.